| DAA24 |
B-cell CLL/lymphoma 11A (zinc finger protein) |
Molecular |
brain |
Human |
BCL11A |
14.0% Decrease Gene Expression Level |
|
| DAA23 |
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) |
Molecular |
brain |
Human |
B3GALNT1 |
22.0% Decrease Gene Expression Level |
|
| DAA1396 |
beta-2 microglobulin |
Molecular |
hippocampus |
Mouse |
B2m |
6.0% Increase Gene Expression Level |
|
| DAA1996 |
Beta-amyloid protein deposition increases |
Physiological |
brain |
Human |
APP |
— |
|
| DAA25 |
bone morphogenetic protein 7 |
Molecular |
brain |
Human |
BMP7 |
20.0% Increase Gene Expression Level |
|
| DAA728 |
Brain matter volume declines |
Physiological |
brain |
Human |
— |
— |
|
| DAA1217 |
Brain volume decrease |
Physiological |
brain |
Human |
— |
— |
|
| DAA1993 |
Brain volume decreases in a regional-specific way |
Physiological |
brain |
Human |
— |
— |
|
| DAA1400 |
cadherin 6 |
Molecular |
hippocampus |
Mouse |
Cdh6 |
9.0% Decrease Gene Expression Level |
|
| DAA33 |
calbindin 1, 28kDa |
Molecular |
brain |
Human |
CALB1 |
58.0% Decrease Gene Expression Level |
|
| DAA765 |
Calcium binding capacity decreases in neurons |
Physiological |
brain |
Human |
— |
— |
|
| DAA36 |
calcium/calmodulin-dependent protein kinase IV |
Molecular |
brain |
Human |
CAMK4 |
17.0% Decrease Gene Expression Level |
|
| DAA37 |
calcium/calmodulin-dependent protein kinase kinase 2, beta |
Molecular |
brain |
Human |
CAMKK2 |
7.0% Decrease Gene Expression Level |
|
| DAA32 |
calcium channel, voltage-dependent, beta 2 subunit |
Molecular |
brain |
Human |
CACNB2 |
8.0% Decrease Gene Expression Level |
|
| DAA34 |
calmodulin 1 (phosphorylase kinase, delta) |
Molecular |
brain |
Human |
CALM1 |
5.0% Decrease Gene Expression Level |
|
| DAA35 |
calmodulin 3 (phosphorylase kinase, delta) |
Molecular |
brain |
Human |
CALM3 |
10.0% Decrease Gene Expression Level |
|
| DAA606 |
Cancer of meninges, brain and other parts of central nervous system |
Pathological |
central nervous system |
Human |
— |
SeriesMorbidity |
|
| DAA44 |
carbamoyl-phosphate synthetase 1, mitochondrial |
Molecular |
brain |
Human |
CPS1 |
20.0% Increase Gene Expression Level |
|
| DAA31 |
carbonic anhydrase XI |
Molecular |
brain |
Human |
CA11 |
6.0% Decrease Gene Expression Level |
|
| DAA2261 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
Molecular |
parietal lobe |
Human |
CASP1 |
40.3% Increase Gene Expression Level |
|
| DAA2259 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
Molecular |
parietal lobe |
Human |
CASP1 |
42.0% Increase Gene Expression Level |
|
| DAA2255 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
Molecular |
hippocampus |
Human |
CASP1 |
137.3% Increase Gene Expression Level |
|
| DAA2254 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
Molecular |
hippocampus |
Human |
CASP1 |
91.8% Increase Gene Expression Level |
|
| DAA2253 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
Molecular |
hippocampus |
Human |
CASP1 |
102.7% Increase Gene Expression Level |
|
| DAA2252 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
Molecular |
hippocampus |
Human |
CASP1 |
101.8% Increase Gene Expression Level |
|